2015 Spring ADRC Meeting presentations

For a PDF of the overall session's agenda, click the session name (e.g., DIRECTORS MEETING).
For an individual presentation, click the presentation title.

Administrators Meeting

Administrators Meeting
Public/private partnerships in research: Perspectives from the Foundation for the National Institutes of Health
Rosa Canet-Aviles, PhD; Scientific Program Manager, Neuroscience, FNIH
Initial development and research applications of PET tau imaging with 18F-AV-1451 (aka 18F-T807)
Mark A. Mintun, MD; Chief Medical Officer, Avid Radiopharmaceuticals
Continuous in-home assessment: New approaches to assessing health
Jeffrey Kaye, MD; Director, Oregon Health & Science University
The not-so-grim RPPR
Cerise Elliott, PhD; Research Program Analyst, Division of Neuroscience, NIA/NIH
Krista Moulder, PhD (panel chair); Associate Administrator, Washington University in St. Louis
Mary Sundsmo, MBA; Administrator, University of California, San Diego
Sleep disorders most pertinent to dementia research: RBD and OSA
Bradley Boeve, MD; Clinical Core Co-Leader, Mayo Clinic
Panel: How do we get it all done? By "standing on the shoulders" of …
Panel: How do we get it all done? By "standing on the shoulders" of …
Senior volunteers in the community
Anne Arthur, APRN, BC; Administrator, University of Kansas
Undergraduate summer interns
Amanda Burden, BA (panel chair); Administrator, Mount Sinai
Apps and technology
Maggie Dean, BS; Research Manager, National Alzheimer's Coordinating Center
The people all around you
Bradley Glazier; Administrator, Indiana University

Directors Meeting

Directors Meeting
NIA update
Richard Hodes, MD; Director, NIA
NACC and UDS3 update
Walter A. Kukull, PhD; Director, National Alzheimer's Coordinating Center
ADGC update
Gerard Schellenberg, PhD; P.I., Alzheimer's Disease Genetics Consortium
NIAGADS update
Gerard Schellenberg, PhD (for Li-San Wang, PhD; P.I., NIAGADS)
NCRAD update
Tatiana Foroud, PhD; P.I., National Cell Repository for Alzheimer's Disease
Scientific symposium: Discovery of therapeutics
Alzheimer's Prevention Initiative
Eric Reiman, MD; Director, Arizona ADRC
Intranasal insulin and Alzheimer’s disease: Diversifying the AD therapeutic portfolio
Suzanne Craft, PhD; Project 2 Leader, University of Washington
Targeting the p75 receptor to inhibit AD degenerative signaling and tau phosphorylation/ misfolding/ missorting: preclinical through phase 1
Frank Longo, MD; Director, Stanford University
Small-molecule modulation of CD33
Elizabeth Bradshaw, PhD; Brigham and Women's Hospital

Clinical Core Leaders Meeting

Clinical Core Leaders Meeting presentations
What should we do until we have a prevention for AD? Practices and investigational approaches to symptom management
Steven E. Arnold, MD; Chair, Clinical Core Leaders Steering Committee
Pharmacological approaches for cognition
Martin R. Farlow, MD; Clinical Core Leader, Indiana University
Physical exercise and non-pharamacological approaches for cognition
Laura D. Baker, PhD; Associate Professor, Wake Forest University
Maximizing independence (MIND) at home and community-based dementia care coordination
Constantine Lyketsos, MD; Clinical Core Leader, Johns Hopkins University
Prazosin for agitation management in dementia
Murray A. Raskind, MD; ORE Core Leader, University of Washington

If you’re unable to find what you’re looking for, please don’t hesitate to contact us.

4311 – 11th Avenue NE, Suite 300, Seattle, WA 98105 |(206) 543-8637 | NACCmail@uw.edu

  • |
  • |
  • |

NACC is funded by the National Institute on Aging (U24 AG072122) and located in the Department of Epidemiology at the University of Washington School of Public Health, Walter A. Kukull, Ph.D., Director. © 2022 University of Washington